Coon SA, White RT, Pagnozzi D, Cowart K, et al. Real-world impact of tirzepatide on the risk of progression to type 2 diabetes and metabolic outcomes in people with obesity and pre-diabetes. Diabetes Obes Metab 2025 Mar 19. doi: 10.1111/dom.16349.
PMID: 40104893